Gastrointestinal Cancer
News
Sanofi Discounts Cancer Drug by 50% After Backlash
News
Fatty Liver Disease Cited for Rise in Hepatocellular Carcinoma
Major Finding: The average number of cases per year of NAFLD-related hepatocellular carcinoma without cirrhosis grew significantly from 51 in 1993...
News
Concurrent Sorafenib and SBRT Too Toxic in Liver Cancer
Major Finding: Only 3 of 16 patients completed a study of concurrent sorafenib and stereotactic body radiation for advanced hepatocellular...
Video
Lower Treatment Cost Doesn't Mean Lower Quality Care
News
Management of Zollinger-Ellison May Depend on Presence of Tumors
News
Evidence Mounts for Continuing Bevacizumab After Colorectal Cancer Progresses
Major Finding: Median progression-free survival was 4.9 months with second-line chemotherapy alone vs. 6.7 months with the addition of bevacizumab...
Audio
Community Oncology Podcast - Cetuximab and FOLFIRI in colon cancer
News
Immunomodulator MGN1703 Cuts Risk of Colorectal Cancer Progressing
Major Finding: Maintenance therapy with MGN1703 reduced the risk of progression by 47% vs. placebo (HR, 0.53; P = .06).Data Source: Phase II/III...
News
Less Liver Cancer in HCV Patients Given Antiviral Therapy
Major Finding: Antiviral therapy for hepatitis C carried a relative risk of 0.53 for developing hepatocellular carcinoma, compared with no...
News
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
News
Screening All Colorectal Tumors Detects Lynch Syndrome Best
Major Finding: Universal screening of colorectal cancers’ DNA for MMR abnormalities had a sensitivity of 100% and a specificity of 93% in...